Contract Research

Inotiv Acquires Genetic Toxicology Assets from Merck's BioReliance® portfolio

Robert Leasure, Jr., President and CEO of Inotiv, commented, “This transaction with MilliporeSigma adds genetic toxicology to our suite of internal c...

 July 14, 2021 | News

Atossa Therapeutics Receives Approval To Open Clinical Study of AT-H201 in Australia

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signi...

 July 08, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

  The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

 June 16, 2021 | News

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

 June 10, 2021 | News

21% were not aware Australian data is accepted by the FDA and other major regulatory authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...

 June 04, 2021 | Analysis


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close